UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 213

Sortiert nach

NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma

Clinical cancer research, 2019-12, Vol.25 (23), p.7126-7138

2019

Volltextzugriff (PDF)

G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (13), p.4134-4146

2013

Volltextzugriff (PDF)

Natural killer T cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapy

Blood, 2023-02, Vol.141 (8), p.869-876

2023

Volltextzugriff (PDF)

Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

Nature medicine, 2020-11, Vol.26 (11), p.1686-1690

2020

Volltextzugriff (PDF)

Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastoma

Journal for immunotherapy of cancer, 2023-03, Vol.11 (3), p.e005478

2023

Volltextzugriff (PDF)

Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy

Blood, 2014-10, Vol.124 (18), p.2824-2833

2014

Volltextzugriff (PDF)

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo

The Journal of clinical investigation, 2016-06, Vol.126 (6), p.2341-2355

2016

Volltextzugriff (PDF)

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo

The Journal of clinical investigation, 2016-06, Vol.126 (6), p.2341-2355

2016

Volltextzugriff (PDF)

Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma

Cancer immunology research, 2020-03, Vol.8 (3), p.309-320

2020

Volltextzugriff (PDF)

TSLP Production by Epithelial Cells Exposed to Immunodeficiency Virus Triggers DC-Mediated Mucosal Infection of CD4⁺ T Cells

Proceedings of the National Academy of Sciences - PNAS, 2009-09, Vol.106 (39), p.16776-16781

2009

Volltextzugriff (PDF)

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Nature medicine, 2023-06, Vol.29 (6), p.1379-1388

2023

Volltextzugriff (PDF)

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity

The Journal of clinical investigation, 2012-06, Vol.122 (6), p.2221-2233

2012

Volltextzugriff (PDF)

IL-21 Selectively Protects CD62L + NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy

The Journal of immunology (1950), 2018-10, Vol.201 (7), p.2141-2153

2018

Volltextzugriff (PDF)

Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Nature medicine, 2024-04, Vol.30 (4), p.1210-1210

2024

Volltextzugriff (PDF)

Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system

Cancer research (Chicago, Ill.), 2014-11, Vol.74 (21), p.6260-6270

2014

Volltextzugriff (PDF)

A Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden

Contrast media and molecular imaging, 2021-06, Vol.2021, p.6641384-9

2021

Volltextzugriff (PDF)

LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells

Cancer immunology research, 2023-02, Vol.11 (2), p.171-183

2023

Volltextzugriff (PDF)

Intranasal but not intravenous delivery of the adjuvant α‐galactosylceramide permits repeated stimulation of natural killer T cells in the lung

European journal of immunology, 2011-11, Vol.41 (11), p.3312-3322

2011

Volltextzugriff (PDF)

Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens

Vaccine, 2009-05, Vol.27 (25), p.3335-3341

2009

Volltextzugriff (PDF)

C-Glycosphingolipids with an exo-Methylene Substituent: Stereocontrolled Synthesis and Immunostimulation of Mouse and Human Natural Killer T Lymphocytes

Chembiochem : a European journal of chemical biology, 2012-08, Vol.13 (12), p.1733-1737

2012

Volltextzugriff (PDF)

Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection

Vaccine, 2007-04, Vol.25 (17), p.3302-3310

2007

Volltextzugriff (PDF)

Multicolor flow cytometry analyses of cellular immune response in rhesus macaques

Journal of visualized experiments, 2010-04 (38)

2010

Volltextzugriff (PDF)

Allogeneic NKT Cells Expressing a CD19-Specific CAR in Patients with Relapsed or Refractory B-Cell Malignancies: An Interim Analysis

Blood, 2021-11, Vol.138 (Supplement 1), p.2819-2819

2021

Volltextzugriff (PDF)

LEF1 activates a central memory-like program in human NKT cells

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.88-88.9

2020

Volltextzugriff (PDF)

IL-21 maintains CD62L expression during NKT-cell ex vivo expansion and enhances antitumor activity of NKT cell therapy in vivo

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.130-130.22

2017

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(181)

Publikationsform

Artikel
(210)
Bücher
(3)

Sprache

Englisch
(212)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma

G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic

Natural killer T cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapy

Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastoma

Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo

Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma

TSLP Production by Epithelial Cells Exposed to Immunodeficiency Virus Triggers DC-Mediated Mucosal Infection of CD4⁺ T Cells

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity

IL-21 Selectively Protects CD62L + NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy

Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system

A Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden

LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells

Intranasal but not intravenous delivery of the adjuvant α‐galactosylceramide permits repeated stimulation of natural killer T cells in the lung

Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens

C-Glycosphingolipids with an exo-Methylene Substituent: Stereocontrolled Synthesis and Immunostimulation of Mouse and Human Natural Killer T Lymphocytes

Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection

Multicolor flow cytometry analyses of cellular immune response in rhesus macaques

Allogeneic NKT Cells Expressing a CD19-Specific CAR in Patients with Relapsed or Refractory B-Cell Malignancies: An Interim Analysis

LEF1 activates a central memory-like program in human NKT cells

IL-21 maintains CD62L expression during NKT-cell ex vivo expansion and enhances antitumor activity of NKT cell therapy in vivo

Suchergebnisse filtern